E-learningEvaluation of treatment
18F-FDG PET/CT
F67
Non-Hodgkin Lymphoma (NHL)
Evaluation of treatment
Teaching point:
Degenerativ facet joint disease may be asymmetric and very intense and may be hard to differentiate from malignancy
To view high resolution images,
please register first.
Click
here
to register.
Already registered? Enter your e-mail in the window below.Re-registerEvaluation of treatment
 | |  | |  |
Evaluation of treatment, | | Evaluation of treatment, | | Evaluation of treatment, |
 | |  | |  |
Evaluation of treatment, | | Evaluation of treatment, | | Evaluation of treatment, |